Products

January 13, 2022

OssDsign to Collect Data on Catalyst Bone Graft

OssDsign to Collect Data on Catalyst Bone Graft
OssDsign will launch a U.S. clinical registry to collect real-world data on Catalyst in spinal fusion applications.
October 25, 2021

Neoss Launches NeoGenix XP Bone Substitute

Neoss Launches NeoGenix XP Bone Substitute
NeoGenix XP more closely resembles natural bone vs. synthetic materials, such as hydroxyapatite or tricalcium phosphate.
October 4, 2021

CoreBone Raises Funds for Bioactive Bone Graft

CoreBone Raises Funds for Bioactive Bone Graft
The investment will be used to extend CoreBone's commercial global presence, primarily in China, with coral-based bone graft.
September 21, 2021

Orthofix Launches Opus Bone Void Filler

Orthofix Launches Opus Bone Void Filler
Opus Mg Set is a magnesium-based settable bone void filler for orthopedic procedures.
September 8, 2021

Study Update: OssDsign Synthetic Bone Graft

Study Update: OssDsign Synthetic Bone Graft
The first patient has been treated in a study to investigate OssDsign Catalyst in patients undergoing spinal fusion.
September 7, 2021

Locate Bio Closes £10 Million Funding Round

Locate Bio Closes £10 Million Funding Round
Proceeds will further advance the company's regenerative medicine pipeline of orthobiologic products.